SCHEMBL70428

SCHEMBL70428

CCCCCCCCc1c(O)cccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 3/20 0.54
MCL1 Q07820 3/20 0.54
BCL2L1 Q07817 2/20 0.54
BAK1 Q16611 2/20 0.54
KAT8 Q9H7Z6 2/20 0.54
PPARG P37231 1/20 0.54
PPARA Q07869 1/20 0.54
EP300 Q09472 1/20 0.54
KAT2A Q92830 1/20 0.54
KAT2B Q92831 1/20 0.54
KAT5 Q92993 1/20 0.54
SAE1 Q9UBE0 1/20 0.54
HTT P42858 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TYR P14679 2/20 0.52
MEN1 O00255 2/20 0.52
MAPT P10636 2/20 0.52
KMT2A Q03164 2/20 0.52
ATM Q13315 1/20 0.52
ESR1 P03372 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545793 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL28345355 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL2370347 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL876099 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL16528762 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL9784636 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL17938799 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL29108 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL22501541 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL28876461 1.00 BID (0.54) BIDMCL1BCL2L1BAK1KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119242964-A Method for inhibiting oxidation of variable-valence rare earth ions in rare earth ion extraction and separation process 兰州大学 2025-01-03 CN claimed
CN-119242931-A Composite liquid inhibitor and preparation method thereof 兰州大学 2025-01-03 CN claimed
CN-119112686-A Composition for delaying oxidation of phenolic hydroxyl compound 西安润玉医疗科技有限公司 2024-12-13 CN claimed
US-12053537-B2 Reduction of stinging sensation on skin SYMRISE AG (DE) 2024-08-06 US claimed
CN-108472220-B Reducing the perception of skin stinging 西姆莱斯股份公司 2022-06-17 CN claimed
EP-3373895-B1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2020-08-19 EP claimed
CN-104414869-B A kind of skin and/or hair whitening mixture 西姆莱斯股份公司 2019-09-03 CN claimed
EP-3373895-A1 REDUCTION OF STINGING SENSATION ON SKIN Symrise AG (DE) 2018-09-19 EP claimed
CN-108472220-A Reduce skin irritation impression 西姆莱斯股份公司 2018-08-31 CN claimed
EP-2842607-B1 A skin and/or hair whitening mixture SYMRISE AG (DE) 2018-05-30 EP claimed
US-20060040847-A1 Hard surface treating compositions RECKITT BENCKISER INC. 2006-02-23 US claimed
WO-2005107456-A2 ANTIMICROBIAL SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-17 WO claimed
CN-1642512-A Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER PLC (NL) 2005-07-20 CN claimed
CN-1642523-A Stabilization of terpenoids in cosmetic compositions UNILEVER PLC (NL) 2005-07-20 CN claimed
CN-1638724-A Stabilization of sunscreens in cosmetic compositions UNILEVER PLC (NL) 2005-07-13 CN claimed
EP-1537201-A1 HARD SURFACE TREATING COMPOSITIONS Reckitt Benckiser Inc. (US) 2005-06-08 EP claimed
EP-0805672-B1 METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH HOMOLA ANDREW M (US) 2004-08-25 EP claimed
WO-2004024861-A1 HARD SURFACE TREATING COMPOSITIONS RECKITT BENCKISER INC (US) 2004-03-25 WO claimed
US-5665333-A Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth PROVSEAL LLC 1997-09-09 US claimed
EP-0021716-B1 CONDENSATION PRODUCT AND LITHOGRAPHIC PRINTING PLATES CONTAINING SAID PRODUCT KONICA CORPORATION (JP) 1984-02-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053537-B2 Reduction of stinging sensation on skin STING1, TYR, CUTA BID 894/4885MCL1 4475/4885BCL2L1 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.